SC
Salil Chopra
About Salil Chopra
Data last updated:
Salil Chopra is a Designated Partner at Varenya Laboratories Llp (since 2023) and Designated Partner at Vaziant Pharmaceuticals Llp (since 2022). The companies operate in Business Services and Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 10 May 2023 | 2023 | Active | ||
| Designated Partner | 25 Jul 2022 | 2021 | Active |
Board colleagues of Salil Chopra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kirti | 10156558 | Varenya Laboratories Llp | Designated Partner |
| Ishaan Kumar | 09330993 | Varenya Laboratories Llp , Vaziant Pharmaceuticals Llp | Designated Partner |
| Tanya Chopra | 09330994 | Varenya Laboratories Llp , Vaziant Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Salil Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Salil Chopra
Salil Chopra currently holds 2 directorships: Varenya Laboratories Llp (Designated Partner, since 10 May 2023); Vaziant Pharmaceuticals Llp (Designated Partner, since 25 Jul 2022).
Salil Chopra was first appointed on 25 Jul 2022 as Designated Partner at Vaziant Pharmaceuticals Llp. The most recent appointment on record is 10 May 2023 at Varenya Laboratories Llp.
The current boards of Salil Chopra's companies include Kirti (Varenya Laboratories Llp), Ishaan Kumar (Varenya Laboratories Llp), Tanya Chopra (Varenya Laboratories Llp).